* Accretive SBBs set to continue in H1'26 * Room for M&A to drive earnings growth * 2026e P/CEPS 11x...
Alcadon surprised on the upside with very strong cash flow in Q4/25, bringing full-year 2025 leasing...
Redeye was surprised to see organic sales growth of 10% in the fourth quarter.
Redeye positively views the inclusion of Nevisense (EIS) in the US National Comprehensive Cancer Net...
Redeye views the Q4 report as a sizable top-line beat, exceeding forecasts by 110% despite the quart...
Actic continued to show good progress in Q4, showcasing good cash flow while lowering leverage to 2.
Thunderful Group is reporting its final quarter and full year as a publicly listed company.
Redeye is positive about the launch of TetraCom, a connectivity platform that enables direct connect...
* Sales +SEK 17m, EBITDA -SEK 1.2m vs. ABGSCe * '26e-'27e EBITDA estimates likely flat * Share to fo...
Sales and earnings in the fourth quarter are mainly in line with our estimates.
Redeye considers GomSpace’s Q4 report to be solid, with 76% y/y growth, which was slightly better th...
* Sales +1% vs. ABGSCe (-13% y-o-y), adj. EBIT +9% vs.
Redeye is optimistic after Medivir's Q4 report. The new programme in osteogenesis imperfecta holds s...
SinterCast levererar fortsatt stark lönsamhet trots ett svagt Q4, där lägre nordamerikanska volymer ...
Starbreeze’s sales came in much lower than expected.
* Q4 sales 20% higher than ABGSCe SEK 41m * Lower gross margin likely due to higher share of partner...
Carlsquare Equity Research har publicerat en kommentar med de första intrycken av Angler Gamings kv4...
* Sales +159% y-o-y on recent orders; +18%/+16% vs.
Redeye provides its initial take on Surgical Science, with sales relatively in line with expectation...
Redeye provides an initial take on the Q4 2025 report from Cheffelo, which, like the preliminary fig...
